New York State Common Retirement Fund’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $164K | Buy |
+68,400
| New | +$133K | ﹤0.01% | 2449 |
|
|
2025
Q2 | – | Sell |
-33,702
| Closed | -$15.5K | – | 3277 |
|
|
2025
Q1 | $15.5K | Hold |
33,702
| – | – | ﹤0.01% | 3016 |
|
|
2024
Q4 | $24.9K | Hold |
33,702
| – | – | ﹤0.01% | 3004 |
|
|
2024
Q3 | $52.9K | Hold |
33,702
| – | – | ﹤0.01% | 2844 |
|
|
2024
Q2 | $56.6K | Sell |
33,702
-31
| -0.1% | -$56 | ﹤0.01% | 3057 |
|
|
2024
Q1 | $81K | Buy |
33,733
+63
| +0.2% | +$135 | ﹤0.01% | 2832 |
|
|
2023
Q4 | $51.5K | Sell |
33,670
-206
| -0.6% | -$245 | ﹤0.01% | 2986 |
|
|
2023
Q3 | $36.9K | Buy |
33,876
+350
| +1% | +$614 | ﹤0.01% | 3094 |
|
|
2023
Q2 | $76.8K | Sell |
33,526
-100
| -0.3% | -$265 | ﹤0.01% | 3014 |
|
|
2023
Q1 | $81.7K | Hold |
33,626
| – | – | ﹤0.01% | 2869 |
|
|
2022
Q4 | $64.2K | Buy |
33,626
+87
| +0.3% | +$185 | ﹤0.01% | 3052 |
|
|
2022
Q3 | $80K | Buy |
33,539
+197
| +0.6% | +$545 | ﹤0.01% | 3063 |
|
|
2022
Q2 | $62K | Sell |
33,342
-157
| -0.5% | -$300 | ﹤0.01% | 3199 |
|
|
2022
Q1 | $70K | Buy |
33,499
+52
| +0.2% | +$144 | ﹤0.01% | 3091 |
|
|
2021
Q4 | $132K | Sell |
33,447
-149
| -0.4% | -$724 | ﹤0.01% | 3008 |
|
|
2021
Q3 | $162K | Sell |
33,596
-24,926
| -43% | -$102K | ﹤0.01% | 2986 |
|
|
2021
Q2 | $269K | Buy |
58,522
+29,322
| +100% | +$141K | ﹤0.01% | 2911 |
|
|
2021
Q1 | $171K | Hold |
29,200
| – | – | ﹤0.01% | 2894 |
|
|
2020
Q4 | $100K | Hold |
29,200
| – | – | ﹤0.01% | 3027 |
|
|
2020
Q3 | $42K | Hold |
29,200
| – | – | ﹤0.01% | 3160 |
|
|
2020
Q2 | $58K | Hold |
29,200
| – | – | ﹤0.01% | 3136 |
|
|
2020
Q1 | $57K | Hold |
29,200
| – | – | ﹤0.01% | 2949 |
|
|
2019
Q4 | $121K | Hold |
29,200
| – | – | ﹤0.01% | 2946 |
|
|
2019
Q3 | $88K | Hold |
29,200
| – | – | ﹤0.01% | 3065 |
|
|
2019
Q2 | $184K | Sell |
29,200
-15,900
| -35% | -$95.2K | ﹤0.01% | 2864 |
|
|
2019
Q1 | $251K | Sell |
45,100
-4,048
| -8% | -$24.6K | ﹤0.01% | 2616 |
|
|
2018
Q4 | $326K | Hold |
49,148
| – | – | ﹤0.01% | 2482 |
|
|
2018
Q3 | $524K | Hold |
49,148
| – | – | ﹤0.01% | 2391 |
|
|
2018
Q2 | $590K | Hold |
49,148
| – | – | ﹤0.01% | 2381 |
|
|
2018
Q1 | $421K | Sell |
49,148
-25,330
| -34% | -$234K | ﹤0.01% | 2425 |
|
|
2017
Q4 | $736K | Buy |
74,478
+18,789
| +34% | +$195K | ﹤0.01% | 2190 |
|
|
2017
Q3 | $684K | Hold |
55,689
| – | – | ﹤0.01% | 2204 |
|
|
2017
Q2 | $916K | Sell |
55,689
-6,547
| -11% | -$101K | ﹤0.01% | 2097 |
|
|
2017
Q1 | $892K | Buy |
62,236
+1
| +0% | +$15 | ﹤0.01% | 2085 |
|
|
2016
Q4 | $861K | Hold |
62,235
| – | – | ﹤0.01% | 2120 |
|
|
2016
Q3 | $1.13M | Buy |
62,235
+10,150
| +19% | +$163K | ﹤0.01% | 1943 |
|
|
2016
Q2 | $747K | Sell |
52,085
-27,471
| -35% | -$373K | ﹤0.01% | 2115 |
|
|
2016
Q1 | $951K | Sell |
79,556
-97,612
| -55% | -$1.02M | ﹤0.01% | 1977 |
|
|
2015
Q4 | $2.36M | Buy |
177,168
+125,083
| +240% | +$1.54M | ﹤0.01% | 1542 |
|
|
2015
Q3 | $559K | Sell |
52,085
-361
| -0.7% | -$3.94K | ﹤0.01% | 2258 |
|
|
2015
Q2 | $422K | Buy |
52,446
+41,160
| +365% | +$302K | ﹤0.01% | 2588 |
|
|
2015
Q1 | $75K | Buy |
+11,286
| New | +$77.1K | ﹤0.01% | 2238 |
|
Other funds holding LXRX
AG
SL
SC
New York State Common Retirement Fund's LXRX Position: Q2 2026 in Review
New York State Common Retirement Fund opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 68,400 shares worth $164K. The stake represents ﹤0.01% of the portfolio and ranks #2449 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in LXRX as recently as Q1 2025.
New York State Common Retirement Fund first reported a position in LXRX in Q1 2015 and has held it in 42 quarters since. The position peaked at $2.36M in Q4 2015. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.
- New York State Common Retirement Fund held 68,400 shares of Lexicon Pharmaceuticals worth $164K as of Q2 2026.
- Lexicon Pharmaceuticals was a new New York State Common Retirement Fund position in Q2 2026.
- Lexicon Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2449 holding.
- New York State Common Retirement Fund first reported a position in Lexicon Pharmaceuticals in Q1 2015 and has held it in 42 quarters since.
- New York State Common Retirement Fund's Lexicon Pharmaceuticals position peaked at $2.36M in Q4 2015.
- 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.